Rural Health
News by Topic: Infectious diseases
Apr 24, 2024 - Profiles the only psychiatrist in Navajo Nation who blends Western behavioral healthcare and cultural practices in his delivery of care. Discusses mental healthcare access, diabetes, recruiting healthcare workforce, and the impact of COVID-19.
Source: Cronkite News
CDC: Solicitation of Nominations for Appointment to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
Federal Register
Apr 22, 2024 - The Centers for Disease Control and Prevention (CDC) is seeking nominations for the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT). The Committee is charged with advising CDC and HRSA on objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STD prevention and treatment efforts. Nominations are due by October 1, 2024.
Source: Federal Register
EOP: COVID-19 and Public Health Preparedness and Response
Federal Register
Apr 17, 2024 - Executive Order from the Office of the President revoking three executive orders related to COVID-19 – Executive Order 13910 of March 23, 2020, Executive Order 13991 of January 20, 2021, and Executive Order 13998 of January 21, 2021. This order also transfers the responsibilities of the Coordinator of the COVID-19 Response and Counselor to the President to the Director of the Office of Pandemic Preparedness and Response Policy (OPPR) and terminates the COVID-19 Response Coordinator and Deputy Coordinator of the COVID-19 Response positions.
Source: Federal Register
Apr 17, 2024 - Summarizes recent research finding that telepharmacy increased access to pharmacy services following the pandemic. Telepharmacy records in a Midwest health system show that use of the service increased significantly between 2019 and 2022, attributed to COVID-19 impacts. Discusses the impact on rural residents.
Source: Specialty Pharmacy Continuum
CDC: Solicitation of Nominations for Appointment to the Healthcare Infection Control Practices Advisory Committee
Federal Register
Apr 15, 2024 - The Centers for Disease Control and Prevention (CDC) is seeking nominations for the Healthcare Infection Control Practices Advisory Committee (HICPAC). HICPAC is charged with advising the Secretary of the Department of Health and Human Services (HHS) and CDC regarding the practice of infection control and strategies for surveillance, prevention, and control of healthcare-associated infections, antimicrobial resistance, and related events in settings where healthcare is provided. Nominations are due by September 30, 2024.
Source: Federal Register
Apr 8, 2024 - Discusses the mortality rate disparity between rural and urban residents following recent research showing the gap has widened to 43% in 2019 from 6% in 1999 for adults between 25 and 54. Offers analysis by experts on causes of this disparity including social vulnerability factors, community vitality, and insurance rates. Discusses the potential impact of COVID-19 on current mortality rates.
Source: CBS News, KFF Health News
Apr 2, 2024 - Highlights population shift trends between urban and rural places. Notes that the highest rural county gains were in those closest to metropolitan areas. Discusses current data alongside pre-pandemic patterns as well as state level trends.
Source: The Daily Yonder
Apr 1, 2024 - Describes challenges rural health systems face when fighting infectious diseases, including shortages of infectious diseases physicians, geographic isolation, and difficulties in accessing mentoring in infection prevention and control.
Source: JAMA Network
Mar 25, 2024 - Summarizes recent research finding that female patients at rural Community Health Centers are more likely to be behind on cervical cancer screenings than patients in urban community health centers. Discusses factors associated with the disparity including English proficiency, income levels, employment, and primary care physician access. Notes that the disparity grew during the COVID-19 pandemic.
Source: Medical Xpress
FDA: Revocation of Six Authorizations of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability
Federal Register
Mar 21, 2024 - The Food and Drug Administration (FDA) has revoked 6 Emergency Use Authorizations issued to Life Technologies Corp.; Bio-Rad Laboratories, Inc.; Revvity, Inc.; bioMérieux SA; and Luminex Corp. related to COVID-19 detection and diagnosis tests.
Source: Federal Register